pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·1 min read
save

MAHA Summit Shows Grassroots Health Movement Aligning with Industry Leaders

Sep 29, 2026·read at STAT ↗Negative

The recent MAHA Summit brought together federal officials and health‑care executives, marking a shift from the movement’s original grassroots stance.

At a panel on affordability, leaders from UnitedHealth Group and Elevance highlighted AI projects while defending prior‑authorization practices that many patients find burdensome.

Observers noted the presence of industry players under the Make America Healthy Again banner raised questions about the movement’s independence and its future direction.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: At MAHA Summit, a grassroots movement goes corporate”

read at STAT ↗
525 words · retrieved 58m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 3h agoSTAT+: Lawmakers urge Trump to rethink new rule that could restrict imported meds from Canada and overseasSTAT
  • 6h agoSTAT+: PhRMA taps Eric Cantor as new CEOSTAT
  • 6h agoSTAT+: Beam Therapeutics sues Chinese biotech, VC-backed startup, alleging theft of intellectual propertySTAT
  • 8h agoSTAT+: Overton won’t get a vote before midtermsSTAT
  • 9h agoSTAT+: Anthropic joins ARPA-H clinical AI moonshot, will hold closed-door health care eventSTAT